CD11301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD11301, covering 2021-04-08 to 2021-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) [Phase 2]